Ranks 4th in the TOP-20 manufacturers in terms of the hospital procurement volume

The annual volume of the company's shipments in this segment amounted to RUB 25.8 billion. At once, three of the company's drugs were included in the TOP-10 INN in terms of import substitution in monetary terms.

Ranks 14th in the TOP-20 manufacturers in the subsidized pharmaceutical provision segment

There was the most evident growth of the company's positions in the subsidized pharmaceutical provision segment: +9 positions and ranks 14th in the rating; +103% by 2020.

Ranks 19th in the TOP-20 manufacturers in terms of sales in the Russian pharmaceutical market

The TOP-20 includes four Russian manufacturers. Pharmasyntez occupied 1.6% market share among all pharmaceutical companies in Russia, including international ones.

Total value of shipments amounted to RUB 33 billion. The increase reached 59.4% by 2020.

The ratings are based on data from DSM Group, an analytical company (Russian Pharmaceutical Market 2021).